Global 
Sverige 
USA Stille AB: Interim Report Q3 2023
Revenue increased in the third quarter by 17.7 percent to 70.1 MSEK (59.6) after strong growth from both business units. “I am pleased to see that our strong growth compared to previous year continued in the third quarter”, comments Torbjörn Sköld.
The gross profit amounted to 46.7 percent (45.1). Business unit Surgical Tables was affected by an unfavorable product and market mix, while Surgical Instruments was positively affected by the same factors. Operating profit amounted to 11.9 MSEK (7.2).
”Stille’s strategic goals remain. With our differentiated high-quality products within surgical instruments and c-arm tables, we focus on niche premium segments. 2023 continues to be strong – We deliver value to our customers, which creates good demand, strong growth and good cashflow”, concludes Stille’s CEO.
| MSEK | JUL-SEP 2023 |
JUL-SEP 2022 |
JAN-SEP 2023 |
JAN-SEP 2022 |
OCT-SEP 2022/23 |
JAN-DEC 2022 |
| Revenue | 70.1 | 59.6 | 217.6 | 184.5 | 279.5 | 246.3 |
| Gross Profit Margin, % | 46.7 | 45.1 | 44.6 | 45.1 | 44.8 | 45.3 |
| EBITDA, before one-time costs | 15.5 | 9.4 | 45.0 | 30.5 | 56.6 | 42.1 |
| EBITDA | 15.5 | 9.4 | 41.7 | 30.4 | 53.3 | 42.1 |
| Operating Profit, before one-time costs |
11.9 | 7.2 | 34.3 | 23.7 | 43.1 | 32.5 |
| Operating Profit | 11.9 | 7.2 | 31.0 | 23.6 | 39.8 | 32.4 |
| Operating Profit, % | 17.0 | 12.1 | 14.2 | 12.8 | 14.2 | 13.2 |
Torshälla, October 26th, 2023.
This information is such information that Stille AB is obliged to disclose according to the EU’s market abuse regulation. The information was, through the agency of the contact person, rendered for publication on October 26th, 2023, kl. 08.00 (CEST).
